Emergent BioSolutions (United Kingdom)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (United Kingdom), United Kingdom, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
71%
Total
Publications
63
Total Open
Publications
45
Total
Citations
766
Open Access
Percentage
71%
Total
Publications
63
Total Open
Publications
45
Total
Citations
766
Breakdown
Publisher Open
36%
Both
29%
Other Platform Open
6%
Closed
29%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
20
Hybrid 24%
10
No Guarantees 27%
11
Other Platform Open
Institution 59%
13
Domain 41%
9
Other Internet 18%
4
Public 14%
3
Preprint 9%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 9 |
University of Oxford - Oxford University Research Archive (ORA) | Institution | 5 |
Europe PMC | Domain | 4 |
whiterose.ac.uk OAI-PMH Repository | Institution | 2 |
Unknown Repository | Other Internet | 2 |
University of Birmingham - University of Birmingham Research Portal | Institution | 2 |
St George's University of London - St George's Online Research Archive | Institution | 2 |
lshtm.ac.uk OAI-PMH Repository | Institution | 2 |
London South Bank University - Research Open | Institution | 2 |
CiteSeer X | Other Internet | 2 |